nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—Prostatitis—Octreotide—thymus cancer	0.062	0.062	CcSEcCtD
Betaxolol—Rectal disorder—Octreotide—thymus cancer	0.0276	0.0276	CcSEcCtD
Betaxolol—Anorectal disorder—Octreotide—thymus cancer	0.0257	0.0257	CcSEcCtD
Betaxolol—Renal pain—Octreotide—thymus cancer	0.0257	0.0257	CcSEcCtD
Betaxolol—Hypothyroidism—Octreotide—thymus cancer	0.0211	0.0211	CcSEcCtD
Betaxolol—Menstrual disorder—Octreotide—thymus cancer	0.0199	0.0199	CcSEcCtD
Betaxolol—Neuralgia—Octreotide—thymus cancer	0.0195	0.0195	CcSEcCtD
Betaxolol—Throat sore—Octreotide—thymus cancer	0.0188	0.0188	CcSEcCtD
Betaxolol—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0186	0.0186	CcSEcCtD
Betaxolol—Otitis media—Octreotide—thymus cancer	0.0174	0.0174	CcSEcCtD
Betaxolol—Numbness—Octreotide—thymus cancer	0.0163	0.0163	CcSEcCtD
Betaxolol—Sensory loss—Octreotide—thymus cancer	0.0156	0.0156	CcSEcCtD
Betaxolol—Breast pain—Octreotide—thymus cancer	0.0155	0.0155	CcSEcCtD
Betaxolol—Oropharyngeal pain—Octreotide—thymus cancer	0.0149	0.0149	CcSEcCtD
Betaxolol—Arthropathy—Octreotide—thymus cancer	0.0149	0.0149	CcSEcCtD
Betaxolol—Muscle twitching—Octreotide—thymus cancer	0.0138	0.0138	CcSEcCtD
Betaxolol—Hyperkalaemia—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Betaxolol—Cystitis noninfective—Octreotide—thymus cancer	0.0132	0.0132	CcSEcCtD
Betaxolol—Cystitis—Octreotide—thymus cancer	0.0131	0.0131	CcSEcCtD
Betaxolol—Neuropathy—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Betaxolol—Cramps of lower extremities—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Betaxolol—Mouth ulceration—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Betaxolol—Bladder pain—Octreotide—thymus cancer	0.0122	0.0122	CcSEcCtD
Betaxolol—Thrombophlebitis—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Betaxolol—Sleep disorder—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Betaxolol—Diabetes mellitus—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Betaxolol—Deafness—Octreotide—thymus cancer	0.011	0.011	CcSEcCtD
Betaxolol—Injury—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Betaxolol—Amnesia—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Betaxolol—Arthritis—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Betaxolol—Hypoglycaemia—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Betaxolol—Osteoarthritis—Octreotide—thymus cancer	0.00983	0.00983	CcSEcCtD
Betaxolol—Psychotic disorder—Octreotide—thymus cancer	0.0096	0.0096	CcSEcCtD
Betaxolol—Cramp muscle—Octreotide—thymus cancer	0.00885	0.00885	CcSEcCtD
Betaxolol—Nasopharyngitis—Octreotide—thymus cancer	0.00879	0.00879	CcSEcCtD
Betaxolol—Influenza—Octreotide—thymus cancer	0.00849	0.00849	CcSEcCtD
Betaxolol—Asthma—Octreotide—thymus cancer	0.00849	0.00849	CcSEcCtD
Betaxolol—Bronchospasm—Octreotide—thymus cancer	0.00835	0.00835	CcSEcCtD
Betaxolol—Bronchitis—Octreotide—thymus cancer	0.00817	0.00817	CcSEcCtD
Betaxolol—Dysuria—Octreotide—thymus cancer	0.00794	0.00794	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Octreotide—thymus cancer	0.00789	0.00789	CcSEcCtD
Betaxolol—Weight increased—Octreotide—thymus cancer	0.00773	0.00773	CcSEcCtD
Betaxolol—Weight decreased—Octreotide—thymus cancer	0.00768	0.00768	CcSEcCtD
Betaxolol—Hyperglycaemia—Octreotide—thymus cancer	0.00766	0.00766	CcSEcCtD
Betaxolol—Pneumonia—Octreotide—thymus cancer	0.00762	0.00762	CcSEcCtD
Betaxolol—Depression—Octreotide—thymus cancer	0.00755	0.00755	CcSEcCtD
Betaxolol—Neuropathy peripheral—Octreotide—thymus cancer	0.00742	0.00742	CcSEcCtD
Betaxolol—Conjunctivitis—Octreotide—thymus cancer	0.00736	0.00736	CcSEcCtD
Betaxolol—Epistaxis—Octreotide—thymus cancer	0.00714	0.00714	CcSEcCtD
Betaxolol—Sinusitis—Octreotide—thymus cancer	0.0071	0.0071	CcSEcCtD
Betaxolol—Bradycardia—Octreotide—thymus cancer	0.00692	0.00692	CcSEcCtD
Betaxolol—Rhinitis—Octreotide—thymus cancer	0.00682	0.00682	CcSEcCtD
Betaxolol—Hypoaesthesia—Octreotide—thymus cancer	0.00676	0.00676	CcSEcCtD
Betaxolol—Pharyngitis—Octreotide—thymus cancer	0.00675	0.00675	CcSEcCtD
Betaxolol—Visual impairment—Octreotide—thymus cancer	0.00655	0.00655	CcSEcCtD
Betaxolol—Tinnitus—Octreotide—thymus cancer	0.00634	0.00634	CcSEcCtD
Betaxolol—Cardiac disorder—Octreotide—thymus cancer	0.00631	0.00631	CcSEcCtD
Betaxolol—Flushing—Octreotide—thymus cancer	0.00631	0.00631	CcSEcCtD
Betaxolol—Immune system disorder—Octreotide—thymus cancer	0.00614	0.00614	CcSEcCtD
Betaxolol—Arrhythmia—Octreotide—thymus cancer	0.00607	0.00607	CcSEcCtD
Betaxolol—Alopecia—Octreotide—thymus cancer	0.00601	0.00601	CcSEcCtD
Betaxolol—Mental disorder—Octreotide—thymus cancer	0.00596	0.00596	CcSEcCtD
Betaxolol—Erythema—Octreotide—thymus cancer	0.00592	0.00592	CcSEcCtD
Betaxolol—Malnutrition—Octreotide—thymus cancer	0.00592	0.00592	CcSEcCtD
Betaxolol—Tension—Octreotide—thymus cancer	0.00581	0.00581	CcSEcCtD
Betaxolol—Nervousness—Octreotide—thymus cancer	0.00575	0.00575	CcSEcCtD
Betaxolol—Muscle spasms—Octreotide—thymus cancer	0.00569	0.00569	CcSEcCtD
Betaxolol—Vision blurred—Octreotide—thymus cancer	0.00558	0.00558	CcSEcCtD
Betaxolol—Tremor—Octreotide—thymus cancer	0.00554	0.00554	CcSEcCtD
Betaxolol—Ill-defined disorder—Octreotide—thymus cancer	0.00549	0.00549	CcSEcCtD
Betaxolol—Anaemia—Octreotide—thymus cancer	0.00547	0.00547	CcSEcCtD
Betaxolol—Malaise—Octreotide—thymus cancer	0.00534	0.00534	CcSEcCtD
Betaxolol—Vertigo—Octreotide—thymus cancer	0.00532	0.00532	CcSEcCtD
Betaxolol—Syncope—Octreotide—thymus cancer	0.00531	0.00531	CcSEcCtD
Betaxolol—Palpitations—Octreotide—thymus cancer	0.00523	0.00523	CcSEcCtD
Betaxolol—Loss of consciousness—Octreotide—thymus cancer	0.0052	0.0052	CcSEcCtD
Betaxolol—Cough—Octreotide—thymus cancer	0.00516	0.00516	CcSEcCtD
Betaxolol—Myalgia—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Betaxolol—Chest pain—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Betaxolol—Arthralgia—Octreotide—thymus cancer	0.00504	0.00504	CcSEcCtD
Betaxolol—Anxiety—Octreotide—thymus cancer	0.00502	0.00502	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.005	0.005	CcSEcCtD
Betaxolol—Discomfort—Octreotide—thymus cancer	0.00498	0.00498	CcSEcCtD
Betaxolol—Dry mouth—Octreotide—thymus cancer	0.00493	0.00493	CcSEcCtD
Betaxolol—Oedema—Octreotide—thymus cancer	0.00483	0.00483	CcSEcCtD
Betaxolol—Infection—Octreotide—thymus cancer	0.0048	0.0048	CcSEcCtD
Betaxolol—Shock—Octreotide—thymus cancer	0.00475	0.00475	CcSEcCtD
Betaxolol—Nervous system disorder—Octreotide—thymus cancer	0.00474	0.00474	CcSEcCtD
Betaxolol—Thrombocytopenia—Octreotide—thymus cancer	0.00473	0.00473	CcSEcCtD
Betaxolol—Tachycardia—Octreotide—thymus cancer	0.00471	0.00471	CcSEcCtD
Betaxolol—Skin disorder—Octreotide—thymus cancer	0.00469	0.00469	CcSEcCtD
Betaxolol—Hyperhidrosis—Octreotide—thymus cancer	0.00467	0.00467	CcSEcCtD
Betaxolol—Anorexia—Octreotide—thymus cancer	0.0046	0.0046	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0044	0.0044	CcSEcCtD
Betaxolol—Insomnia—Octreotide—thymus cancer	0.00437	0.00437	CcSEcCtD
Betaxolol—Paraesthesia—Octreotide—thymus cancer	0.00434	0.00434	CcSEcCtD
Betaxolol—Dyspnoea—Octreotide—thymus cancer	0.00431	0.00431	CcSEcCtD
Betaxolol—Dyspepsia—Octreotide—thymus cancer	0.00425	0.00425	CcSEcCtD
Betaxolol—Decreased appetite—Octreotide—thymus cancer	0.0042	0.0042	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Octreotide—thymus cancer	0.00417	0.00417	CcSEcCtD
Betaxolol—Fatigue—Octreotide—thymus cancer	0.00416	0.00416	CcSEcCtD
Betaxolol—Pain—Octreotide—thymus cancer	0.00413	0.00413	CcSEcCtD
Betaxolol—Constipation—Octreotide—thymus cancer	0.00413	0.00413	CcSEcCtD
Betaxolol—Feeling abnormal—Octreotide—thymus cancer	0.00398	0.00398	CcSEcCtD
Betaxolol—Urticaria—Octreotide—thymus cancer	0.00384	0.00384	CcSEcCtD
Betaxolol—Body temperature increased—Octreotide—thymus cancer	0.00382	0.00382	CcSEcCtD
Betaxolol—Hypersensitivity—Octreotide—thymus cancer	0.00356	0.00356	CcSEcCtD
Betaxolol—Asthenia—Octreotide—thymus cancer	0.00347	0.00347	CcSEcCtD
Betaxolol—Pruritus—Octreotide—thymus cancer	0.00342	0.00342	CcSEcCtD
Betaxolol—Diarrhoea—Octreotide—thymus cancer	0.0033	0.0033	CcSEcCtD
Betaxolol—Dizziness—Octreotide—thymus cancer	0.00319	0.00319	CcSEcCtD
Betaxolol—Vomiting—Octreotide—thymus cancer	0.00307	0.00307	CcSEcCtD
Betaxolol—Rash—Octreotide—thymus cancer	0.00305	0.00305	CcSEcCtD
Betaxolol—Dermatitis—Octreotide—thymus cancer	0.00304	0.00304	CcSEcCtD
Betaxolol—Headache—Octreotide—thymus cancer	0.00303	0.00303	CcSEcCtD
Betaxolol—Nausea—Octreotide—thymus cancer	0.00287	0.00287	CcSEcCtD
